Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Klatskin Tumor × Optical Imaging × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Mouth Neoplasms 3 Carcinoma, Renal Cell 3 Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Skin Neoplasms 2 Urinary Tract Infections 1 Tongue Neoplasms 1 Tobacco Use Disorder 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma 1 Mouth Diseases 1 Lymphoid Interstitial Pneumonia 1 Lymphatic Metastasis 1 Lung Neoplasms 1 Lichen Planus 1 Leukokeratosis, Hereditary Mucosal 1 Klatskin Tumor 1 Fanconi Anemia 1 Erythroplasia 1 Colonic Polyps 1 Colonic Neoplasms 1 Colonic Diseases 1 Carcinoma, Transitional Cell 1

Interventions

Capecitabine 6 Gemcitabine 5 Cisplatin 5 Liver Transplantation 4 Radiosurgery 3 Fluorouracil 3 toripalimab 2 Specimen Handling 2 Self Expandable Metallic Stents 2 Oxaliplatin 2 Magnetic Resonance Spectroscopy 2 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 2 trisacryl gelatin microspheres 1 tremelimumab 1 trametinib 1 tislelizumab 1 temoporfin 1 sacituzumab govitecan 1 pembrolizumab 1 lenvatinib 1 gemcitabine-oxaliplatin regimen 1 durvalumab 1 dehydroftorafur 1 Tegafur 1 Stents 1 Sorafenib 1 Saline Solution 1 S 1 (combination) 1 Radiofrequency Ablation 1 Platinum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03620292 2021-04-28

COUGAR

University Medical Center Groningen

Phase 1/2 Unknown

Gastrointestinal

Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡